Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-83,269
Closed -$6.94M 40
2018
Q1
$6.94M Sell
83,269
-2,640
-3% -$238K 1.17% 29
2017
Q4
$8.14M Sell
85,909
-734
-0.8% -$76.7K 1.46% 28
2017
Q3
$10.1M Sell
86,643
-4,441
-5% -$562K 1.86% 23
2017
Q2
$11.5M Buy
91,084
+9,261
+11% +$1.18M 2.08% 18
2017
Q1
$10.9M Sell
81,823
-6,613
-7% -$842K 2.11% 18
2016
Q4
$8.87M Sell
88,436
-16,206
-15% -$1.58M 1.75% 24
2016
Q3
$9.87M Buy
104,642
+25,990
+33% +$2.19M 1.55% 27
2016
Q2
$6.29M Buy
+78,652
New +$6.11M 0.91% 34

Other funds holding INCY

Ithaka Group's INCY Position: Q2 2018 in Review

Ithaka Group sold out of Incyte (INCY) in Q2 2018, closing a stake of 83,269 shares — an estimated $6.94M sold.

Ithaka Group first reported a position in INCY in Q2 2016 and held it in 8 quarters. The position peaked at $11.5M in Q2 2017. 452 funds tracked by Wall St. Rank hold INCY as of Q2 2018.

  • Ithaka Group reported no remaining Incyte position as of Q2 2018 after selling out during the quarter.
  • Ithaka Group sold 83,269 Incyte shares in Q2 2018, an estimated $6.94M.
  • Ithaka Group first reported a position in Incyte in Q2 2016 and held it in 8 quarters.
  • Ithaka Group's Incyte position peaked at $11.5M in Q2 2017.
  • 452 funds tracked by Wall St. Rank held Incyte as of Q2 2018.

Based on Ithaka Group's 13F filing for Q2 2018, filed 13 Aug 2018.